Long term, tamoxifen stops more cancer than Evista
Longer-term results from a head-to-head trial of two drugs that prevent breast cancer shows that tamoxifen works better than rival Eli Lilly and Co’s Evista, but with a greater risk of some other cancers and blood clots.
Read more on Reuters via Yahoo! News
Using gold nanoparticles to hit cancer where it hurts
( Georgia Institute of Technology ) Scientists at the Georgia Institute of Technology have shown that by directing gold nanoparticles into the nuclei of cancer cells, they can not only prevent them from multiplying, but can kill them where they lurk.
Read more on EurekAlert!
The Institute Of Cancer Research Receives Environmental Honour
The Institute of Cancer Research (ICR) is pleased to announce that it will be presented with the EcoCampus Bronze Certificate on 3rd February in recognition of its commitment to improve environmental sustainability. EcoCampus is a scheme designed to encourage and provide tools to assist higher educational institutions in creating and maintaining good environmental and management practices. The …
Read more on Medical News Today